Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling
- 1 January 2009
- journal article
- review article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 20 (1) , 14-27
- https://doi.org/10.1016/j.drugpo.2007.12.006
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York CityAIDS, 2007
- Implementation and Analysis of Respondent Driven Sampling: Lessons Learned from the FieldJournal of Urban Health, 2006
- Effectiveness of Respondent-Driven Sampling for Recruiting Drug Users in New York City: Findings from a Pilot StudyJournal of Urban Health, 2006
- Informed Consent Revisited: Japan and the U.S.American Journal of Bioethics, 2006
- ???Informed Altruism??? and ???Partner Restriction??? in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990???2001JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Modified informed consent procedure: consent to postponed informationBMJ, 2003
- Serostatus disclosure, sexual communication and safer sex in HIV-positive menAIDS Care, 2003
- HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health interventionAmerican Journal of Public Health, 2001
- Drug Users versus Outreach Workers in Combating Aids: Preliminary Results of a Peer-Driven InterventionJournal of Drug Issues, 1995
- Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior.Psychological Bulletin, 1990